Johannes Hulthe

Johannes Hulthe

Director/Board Member chez GUARD THERAPEUTICS INTERNATIONAL AB

54 ans
Commercial Services
Health Technology
Consumer Services

Profil

Dr. Johannes Hulthe, MD, is an Independent Director at Lipigon Pharmaceuticals AB, an Independent Director at Guard Therapeutics International AB, a Chairman at Antaros Renostic AB and a Chief Executive Officer & Director at Antaros Medical AB.
He is on the Board of Directors at Lipigon Pharmaceuticals AB, Guard Therapeutics International AB, Antaros Medical AB, Antaros Holding AB and Metynex Pharmaceuticals AB.
Dr. Hulthe was previously employed as a Vice President by AstraZeneca AB.
He received his graduate degree from the University of Gothenburg and a doctorate degree from the University of Gothenburg.

Postes actifs de Johannes Hulthe

SociétésPosteDébut
GUARD THERAPEUTICS INTERNATIONAL AB Director/Board Member 29/05/2019
LIPIGON PHARMACEUTICALS AB Director/Board Member 01/01/2020
Founder -
Antaros Renostic AB Chairman -
Antaros Holding AB Director/Board Member -
Metynex Pharmaceuticals AB Director/Board Member -
Tous les postes actifs de Johannes Hulthe

Anciens postes connus de Johannes Hulthe

SociétésPosteFin
Corporate Officer/Principal 01/01/2014
Voir l'expérience en détail de Johannes Hulthe

Formation de Johannes Hulthe

University of Gothenburg Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Johannes Hulthe

Relations

23

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
GUARD THERAPEUTICS INTERNATIONAL AB

Health Technology

LIPIGON PHARMACEUTICALS AB

Health Technology

Entreprise privées5

Commercial Services

Commercial Services

Antaros Renostic AB

Antaros Holding AB

Metynex Pharmaceuticals AB

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Johannes Hulthe